GlassScriptPhysician profile
Cagri Cakmakoglu
NPI 1053852566
$14,291.99
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,659 · 2022: $2,032 · 2023: $391 · 2024: $2,066 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,444 · Food and Beverage: $1,156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,443.83 |
| Food and Beverage | $1,156.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $8,087.67 | 2019 | |
| Allergan, INC. | $3,216.86 | 2019-2022 | |
| Abbvie INC. | $2,131.51 | 2023-2025 | |
| Integra Lifesciences Corporation | $468.40 | 2022-2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $123.74 | 2023 | |
| Horizon Therapeutics Plc | $113.72 | 2019 | |
| Mentor Worldwide LLC | $69.87 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Dilon Technologies, INC. | $49.61 | 2023 | Hemoblast Bellows |
| Motiva USA, LLC | $30.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cagri Cakmakoglu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.